The Pfizer papers; Biogen layoffs begin; AbbVie inks a buyout; GSK makes Slaoui pay; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
We are saddened this week to say goodbye to our managing editor, Kyle Blankenship, as he begins a new chapter in his career. But we are equally grateful for the time together and excited about the team he’s helped shape.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.